Related Experiment Video
Updated: Jun 7, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
[Study on in-vitro susceptibility of ESBL-positive Escherichia coli isolated from urine specimens]
Stefano Grandesso1, Barbara Sapino, Sandra Mazzucato
1Struttura Semplice Dipartimentale di Microbiologia, Ospedale dell'Angelo, Mestre, Venice, Italy.
Abstract:
Treatment of infections by beta-lactamase-producing microorganisms is very difficult. Our aim was to determine the in vitro susceptibility of 430 ESBL-positive Escherichia coli strains isolated from urinary tract infections. All the microorganisms were isolated in the Microbiology Unit at the Ospedale dell'Angelo in Mestre (Venice) between May 2008 and September 2009 and were confirmed by the double-disk test. All microorganisms were sensitive to imipenem and meropenem, 98.4% to tigecycline, 95.1% to amikacin, 89.3% to nitrofurantoin, 67.5% to gentamycin and 63.2% to piperacillin/tazobactam. Only 22.6% were sensitive to cotrimoxazole, while fluoroquinolone (norfloxacin and levofloxacin) activity was found to be very low (6%).
More Related Videos
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Microbiota of the Urogenital Tract

